CM-47669-02/CM/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
1988	1
1989	1
1990	1
2024	0

Page 1

Repetitive weekly cycles of interleukin-2. II. Clinical and immunologic effects of dose, schedule, and addition of indomethacin.

Sosman JA, Kohler PC, Hank JA, Moore KH, Bechhofer R, Storer B, Sondel PM. Sosman JA, et al. J Natl Cancer Inst. 1988 Nov 16;80(18):1451-61. doi: 10.1093/jnci/80.18.1451. J Natl Cancer Inst. 1988. PMID: 3263508 Clinical Trial.

"Lymphokine activated killing" as treatment for human cancer: clinical extrapolations from laboratory studies with interleukin-2 expanded leukocytes.

Sondel PM, Hank JA, Kohler PC, Chen BP, Sosman J. Sondel PM, et al. Prog Clin Biol Res. 1989;288:151-60. Prog Clin Biol Res. 1989. PMID: 2654949 Review. No abstract available.

Addition of interleukin-2 in vitro augments detection of lymphokine-activated killer activity generated in vivo.

Hank JA, Weil-Hillman G, Surfus JE, Sosman JA, Sondel PM. Hank JA, et al. Cancer Immunol Immunother. 1990;31(1):53-9. doi: 10.1007/BF01742496. Cancer Immunol Immunother. 1990. PMID: 2306756 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year